Clinical Trial: Comparison of HBW-3220 Capsule Formulations and the Effect of Food in Healthy Participants

U.S., Sept. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07799597) titled 'Comparison of HBW-3220 Capsule Formulations and the Effect of Food in Healthy Participants' on Aug. 30.

Brief Summary: This Phase 1 study will evaluate a new formulation of HBW-3220 capsules in healthy adults. It will compare how much and how quickly HBW-3220 enters the bloodstream after a single 120 mg dose of the new formulation versus the previous formulation under fasting conditions, and after the new formulation is taken under fed versus fasting conditions. Twenty-one participants will be randomly assigned to one of three treatment sequences and will receive all three treatments during three study periods, with at least 7 days ...